FDA Import Refusal 799-5960207-9/11/1 — Boehringer Ingelheim Pharma GmbH & Co. KG
The FDA refused shipment 799-5960207-9/11/1 from Boehringer Ingelheim Pharma GmbH & Co. KG (Germany) on Jul 28, 2023. The refused product falls under Drugs and Biologics — EMPAGLIFLOZIN (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Jul 28, 2023
- Country
- Germany
- Product Category
- Drugs and Biologics
- Product Code
- 61PDA73 EMPAGLIFLOZIN (ANTI-DIABETIC)
- Charges
- 75